• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Most Common Treatment for Prostate Cancer Not Best Value

Article

External beam radiation is the most toxic and expensive among common prostate cancer treatments over the long-term, a national registry study suggested.

Although it's one of the most common treatments for Medicare patients with prostate cancer, external beam radiation had the highest 16-year cumulative risk of serious gastrointestinal and genitourinary problems compared with surgery and brachytherapy, Jay Ciezki, MD, of the Cleveland Clinic, and colleagues found.

External beam radiation also cost twice as much as either of the other treatments when adding up initial treatment plus management of complications, he reported at a press briefing ahead of presentation at the Genitourinary Cancers Symposium here.

The average cost per patient-year was $6,412 with external radiation versus $3,206 with open prostatectomy and $2,557 for brachytherapy (P<0.0001).

Read more about this study at: http://tinyurl.com/83qzpsx

Source: MedPage Today

Related Videos
Chicago skyline with words "CHEST 2025 Recap Chicago, Illinois" | Image credit: SeanPavonePhoto - stock.adobe.com
Dr Brian Mulherin
Dr Brian Koffman
Dr Brian Mulherin
Lindsey Valenzuela, PharmD, APh, BCACP - screenshot by AJMC
Dr Vivek Subbiah
Robert Andrews, former US representative for New Jersey and CEO of the Health Transformation Alliance
Dr Scott Soefje
Robert Andrews, chief executive officer, Health Transformation Alliance
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.